NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) - NICE TAG TA576

Bosutinib for untreated chronic myeloid leukaemia (terminated appraisal) - NICE TAG TA576

NICE is unable to make a recommendation about the use in the NHS of bosutinib (Bosulif) for untreated chronic myeloid leukaemia in adults because no evidence submission was received from Pfizer. We will review this decision if the company decides to make a submission.

https://www.nice.org.uk/guidance/ta576

Site by Devopa
© Copyright 2019 NHS. All rights reserved.